PRHSX β€” T. ROWE PRICE HEALTH SCIENCES

Ownership history in Coston, McIsaac & Partners  Β·  14 quarters on record

AI Ownership Summary

Coston, McIsaac & Partners reported T. ROWE PRICE HEALTH SCIENCES (PRHSX) in 14 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.03% in 2023 Q4. The latest visible filing shows PRHSX at 0.02% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PRHSX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Coston, McIsaac & Partners's position in T. ROWE PRICE HEALTH SCIENCES, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

PRHSX was reported at 0.02% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.03% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Coston, McIsaac & Partners held PRHSX β€” position size vs. price
% of Fund (quarterly)    PRHSX price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 9 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 790 +84 +11.9% 0.02% $66K 2026-02-14 (Est.) $82.04
2025 Q3 UNCHANGED 706 β€” 0% 0.01% $57K 2025-11-05 $68.40
2025 Q2 UNCHANGED 706 β€” 0% 0.01% $54K 2025-08-12 $59.52
2025 Q1 REDUCED 706 -250 -26.2% 0.02% $56K 2025-05-13 $58.08
2024 Q4 ADDED 956 +107 +12.6% 0.02% $76K 2025-01-23 $65.93
2024 Q3 UNCHANGED 849 β€” 0% 0.02% $85K 2024-10-22 $60.54
2024 Q2 UNCHANGED 849 β€” 0% 0.03% $80K 2024-07-31 $59.47
2024 Q1 UNCHANGED 849 β€” 0% 0.03% $80K 2024-04-17 $54.42
2023 Q4 ADDED 849 +43 +5.3% 0.03% $74K 2024-01-23 $54.54
5 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

FAQ About Coston, McIsaac & Partners and PRHSX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Coston, McIsaac & Partners reported owning PRHSX?

Coston, McIsaac & Partners reported PRHSX across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported PRHSX position in Coston, McIsaac & Partners's portfolio?

The largest reported portfolio weight for PRHSX was 0.03% in 2023 Q4.

What is the latest reported PRHSX position on this page?

The most recent filing on this page is 2025 Q4, when Coston, McIsaac & Partners reported 790 shares, equal to 0.02% of portfolio, with an estimated market value of $66K.

What does the chart on this PRHSX ownership page compare?

The chart compares Coston, McIsaac & Partners's quarterly PRHSX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Coston, McIsaac & Partners Holdings